Home » Topics » BioWorld Science

BioWorld Science
RSS

Long in the making changes lead to tipping point in blood stem cells

June 3, 2022

SHH expression is required for bone regeneration in a murine model

June 3, 2022

Chimeric switch-receptor PD1-DAP10-41BB augments NK92 cell antitumor activity

June 3, 2022

FDA accepts IND for novel oral immune checkpoint inhibitor, TT-816

June 3, 2022

Tau-targeting therapy reduces epilepsy and autism behaviors in model of Dravet syndrome

June 3, 2022

RIKEN presents new immunostimulants

June 3, 2022

New lysophosphatidic acid receptor 1 antagonists patented by Humanwell Healthcare

June 3, 2022

Guangzhou Henovcom Bioscience discovers autotaxin inhibitors

June 3, 2022

Hongyun Biotech presents new MAP4K1 inhibitors

June 3, 2022

New Rho kinase 2 inhibitors identified at Medshine Discovery

June 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...